// COMPANY
Oyster Therapeutics
SECTOR BIOTECHMENTIONS 2LAST SEEN NOVEMBER 11, 2026
Discussed in
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
funding·StrictlyVC·NOVEMBER 11, 2026
“Oyster Therapeutics... develops oral medicines that remove harmful tau proteins from brain cells to treat Alzheimer's and other neurodegenerative diseases, raised a $60M Series A with Eli Lilly participating.”
Source→02
funding·PitchBook News·NOVEMBER 11, 2026
“raised a $60 million Series A-2 led by 4BIO Capital.”
Source→AI-extracted from podcast / newsletter / paper summaries. May contain errors.